We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
LYNKUET Bayer Australia Ltd
Product name
LYNKUET
Sponsor
Accepted date
Oct-2025
Active ingredients
elinzanetant
Summary of proposed indication
Lynkuet (elinzanetant) is used to treat moderate to severe vasomotor symptoms (VMS; hot flushes and night sweats) that happen during menopause or that are caused by hormone therapy.
Application type
C (new indication)
Publication date
Oct-2025